CLEARSIDE BIOMEDICAL INC
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 30
- Market Cap
- $75.4M
- Website
- http://www.clearsidebio.com
Clinical Trials
34
Trial Phases
3 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
- Conditions
- Neovascular Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Clearside Biomedical, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05891548
- Locations
- 🇺🇸
Associated Retina Consultants, Phoenix, Arizona, United States
🇺🇸Retinal Research Institute, LLC, Phoenix, Arizona, United States
🇺🇸California Retina Consultants, Bakersfield, California, United States
Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Clearside Biomedical, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05131646
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Northern California Retina Vitreous Associates Medical Group, LLC, Mountain View, California, United States
🇺🇸Retina Consultants Medical Group, Inc, Sacramento, California, United States
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
- Conditions
- Neovascular Age-related Macular Degeneration
- Interventions
- Drug: Anti-VEGF
- First Posted Date
- 2020-11-12
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Clearside Biomedical, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT04626128
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸California Retina Consultants, Bakersfield, California, United States
🇺🇸Northern California Retina Vitreous Associates Medical Group, LLC, Mountain View, California, United States
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
- Conditions
- Retinal Vein OcclusionMacular Edema
- Interventions
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Clearside Biomedical, Inc.
- Target Recruit Count
- 325
- Registration Number
- NCT03203447
- Locations
- 🇺🇸
Retinal Research Institute, Phoenix, Arizona, United States
🇺🇸Retina Centers PC, Tucson, Arizona, United States
🇺🇸Retina Associates Southwest PC, Tucson, Arizona, United States
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
- Conditions
- Diabetic Macular Edema
- Interventions
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Clearside Biomedical, Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT03126786
- Locations
- 🇺🇸
Retinal Consultants of Arizona and Retinal Research Institute, Phoenix, Arizona, United States
🇺🇸Retina Centers, PC, Tucson, Arizona, United States
🇺🇸California Retina Consultants, Bakersfield, California, United States
- Prev
- 1
- 2
- 3
- Next